Universität Wien
Course Exam

301907 VO Development of novel cancer immunotherapies (2019W)

from target identification through target validation to clinical trials

2.00 ECTS (1.00 SWS), SPL 30 - Biologie

Sunday 01.03.2020

Examiners

Information

Assessment and permitted materials

written exam

Minimum requirements and assessment criteria

100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)

Last modified: We 19.08.2020 07:49